Discover how to track all 535 Congress member stock trades today. This brings the company’s total U.S. capital expansion commitments to over $50 billion since 2020. Also Read: Eli Lilly Expands ...

World shares are mixed after U.S. stock indexes were little changed and Nvidia reported strong profits for the last quarter BANGKOK -- World shares were mixed Thursday after U.S. stock indexes ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli Lilly and Company (NYSE:LLY) even as it fell into a bear market after peaking in August.

Eli Lilly and Company (NYSE ... and reflects the market conditions and analyst perspectives as of that date. While the stock is currently trading near its 52-week high with high valuation ...

Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases. In one, Lilly announced plans to acquire the farnesoid X ...

Eli Lilly (NYSE:LLY) announced Tuesday it expanded its weight loss drug offerings, launching new 7.5 mg and 10 mg single-dose vial formats of its popular weight loss therapy Zepbound (tirzepatide ...

Eli Lilly is buying a new drug and lowering prices ... It's as simple as that -- and good enough for a 2.6% stock price bump. Rich Smith has no position in any of the stocks mentioned.

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...